Abstract
Objective To explore the curative effect of sodium citrate anticoagulant for hemoperfusion on hypertriglyceridemia-induced acute pancreatitis in pregnancy. Methods A retrospective study was conducted in 19 pregnant patients with hypertriglyceridemia-induced acute pancreatitis. The clinical manifestation and laboratory index of the patients before and after hemoperfusion with sodium citrate anticoagulant were compared. Results After hemoperfusion with sodium citrate anticoagulant, the ACPAHEⅡscores of patients reduced from(14.8±4.7) scores to (6.3±1.3) scores, t=5.167, triglyceride from(30.44±7.37) mmol/L to(4.5±1.2) mmol/L, t=5.167, amylase from (1028.76±293.27)U/L to (105.3±65.1)U/L, t=2.861, all P<0.01. Conclusion The hemoperfusion with sodium citrate anticoagulant can improve clinical symptom and prognosis of pregnant patients with hypertriglyceridemia-induced acute pancreatitis. Key words: Poncirus; Perfusion; Blood; Pregnancy complications; Hyperlipidemias; Pancreatitis
Sign-in/Register to access full text options 
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
